Left ventricular hemodynamic parameters in the course of acute experimental coxsackievirus B 3 myocarditis.
暂无分享,去创建一个
H. Jomaa | M. Herzum | H. Jomaa | B. Maisch | S. Pankuweit | R. Weller | F. Wietrzychowski | P. Mahr | B. Maisch
[1] M. Herzum,et al. Coxsackievirus B3 infection leads to cell death of cardiac myocytes. , 1994, Journal of molecular and cellular cardiology.
[2] T. N. James,et al. Ultrastructural alterations of the conduction system in mice exhibiting sinus arrest or heart block during Coxsackievirus B3 acute myocarditis. , 1992, American heart journal.
[3] M. Herzum,et al. Treatment of experimental murine Coxsackie B3 myocarditis. , 1991, European Heart Journal.
[4] W. Abelmann,et al. Natural evolution of cardiac function, cardiac pathology and antimyosin scan in a murine myocarditis model. , 1991, Journal of the American College of Cardiology.
[5] R. Kloner,et al. Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis. , 1990, American heart journal.
[6] W. Abelmann,et al. Immunosuppression with high doses of cyclophosphamide reduces the severity of myocarditis but increases the mortality in murine Coxsackievirus B3 myocarditis. , 1990, Circulation.
[7] J E Parrillo,et al. A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy. , 1989, The New England journal of medicine.
[8] B. Pitt,et al. Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group. , 1989, Journal of the American College of Cardiology.
[9] H. Schultheiss,et al. Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo. , 1989, Circulation research.
[10] P. Lodge,et al. Coxsackievirus B-3 myocarditis. Acute and chronic forms of the disease caused by different immunopathogenic mechanisms. , 1987, The American journal of pathology.
[11] N. Bowles,et al. DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY , 1986, The Lancet.
[12] W. Abelmann,et al. Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus. , 1986, Circulation.
[13] A. Matsumori,et al. Effects of prednisolone on acute viral myocarditis in mice. , 1986, Journal of the American College of Cardiology.
[14] P. Lodge,et al. Coxsackievirus B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/c mice. , 1986, The American journal of pathology.
[15] J. Robinson,et al. The effects of cyclosporine on acute murine Coxsackie B3 myocarditis. , 1986, Circulation.
[16] K. Beisel,et al. Heart-specific autoantibodies following murine coxsackievirus B3 myocarditis , 1985, The Journal of experimental medicine.
[17] Craven Pc. Interaction of ketoconazole with rifampin and isoniazid. , 1985, New England Journal of Medicine.
[18] Woodruff Jf. Viral myocarditis. A review. , 1980 .
[19] J. Mason,et al. Treatment of acute inflammatory myocarditis assisted by endomyocardial biopsy. , 1980, The American journal of cardiology.
[20] N. Grist,et al. Coxsackie viruses and the heart. , 1969, American heart journal.
[21] K. Klingel,et al. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[22] B. Maisch. Immunologic regulator and effector functions in perimyocarditis, postmyocarditic heart muscle disease and dilated cardiomyopathy. , 1986, Basic research in cardiology.